Inhaled Drug Delivery - Formulation Development

Pharmaterials provides a contract, fee for service, offering for the formulation of dry powder inhalers (DPIs) and pressurised metered dose inhalers (pMDIs).

Whatever your respiratory drug delivery needs we are happy to provide:

• early stage preformulation support,
• materials characterisation,
• formulation development and
• in vitro testing of prototype formulations. 

Our service can start from selection of the optimum physical form, understanding the effect of micronisation on the amorphous content of the API (with validated quantification of amorphous content determination), the selection of an inhaler device and the optimisation of the formulation.

Our staff understand the vital physico-chemical concepts and have authored a number of patent applications and many publications relating to inhaled drug delivery.

We are ready and able to assist with your inhalation needs.

Please contact us for full details of this service at enquiries@pharmaterials.co.uk